18F-FDG-FR
18F-FDG-FR is a medicine authorised by Swissmedic under authorisation number 55758. The authorisation holder is Posimed Radiopharm AG. The medicinal product code is Radiopharmaceuticals and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 04 February 2002 and the authorisation is valid without a time limit. ATC code V09IX04 places the medicine in the group Diagnostic radiopharmaceuticals.
| Authorisation number | 55758 |
|---|---|
| Name | 18F-FDG-FR |
| Full name | 18F-FDG-FR, Injektionslösung |
| Authorisation holder | Posimed Radiopharm AG |
| Medicinal product code | Radiopharmaceuticals |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | V09IX04 |
| First authorisation | 04 February 2002 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | 18F-FDG-FR, Injektionslösung | A | 14 December 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 15 | ml | V09IX04 | 17.01.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is 18F-FDG-FR authorised in Switzerland?
Yes. 18F-FDG-FR is authorised by Swissmedic under authorisation number 55758, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does 18F-FDG-FR have?
18F-FDG-FR is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of 18F-FDG-FR?
The authorisation holder is Posimed Radiopharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.